carbamazepine has been researched along with chitosan in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Filipović-Grcić, J; Jalsenjak, I; Martinac, A; Moneghini, M; Perissutti, B; Voinovich, D | 1 |
Gavini, E; Giunchedi, P; Hegge, AB; Karlsen, J; Pirisino, G; Rassu, G; Sanna, V; Testa, C | 1 |
Mashru, RC; Rane, YM; Sankalia, MG; Shah, PP; Sutariya, VB | 1 |
Li, P; Liu, HJ; Wei, Q | 1 |
Kumar, AC; Nair, R; Priya, VK; Raju, PY; Yadav, CM | 1 |
Dai, CM; Liu, SG; Zhang, J; Zhang, YL; Zhou, XF | 1 |
Dai, C; Shen, Z; Zhang, Y; Zhou, X | 1 |
Bach, M; Bäurer, B; Mirzayeva, A; Riegger, BR; Tovar, GEM | 1 |
Ana, R; Falcão, A; Fortuna, A; Mendes, M; Pais, A; Sousa, J; Vitorino, C | 1 |
Sağıroğlu, AA | 1 |
10 other study(ies) available for carbamazepine and chitosan
Article | Year |
---|---|
Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
Topics: Anticonvulsants; Calorimetry, Differential Scanning; Carbamazepine; Chitin; Chitosan; Delayed-Action Preparations; Hypromellose Derivatives; Methylcellulose; Microspheres; Molecular Weight; Particle Size; Solubility; Technology, Pharmaceutical; X-Ray Diffraction | 2003 |
Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
Topics: Administration, Intranasal; Animals; Anticonvulsants; Calorimetry, Differential Scanning; Carbamazepine; Chitosan; Drug Carriers; Drug Compounding; Microscopy, Electron, Scanning; Microspheres; Nasal Mucosa; Particle Size; Sheep; Solubility | 2006 |
Investigations on factors affecting chitosan for dissolution enhancement of oxcarbazepine by spray dried microcrystal formulation with an experimental design approach.
Topics: Anticonvulsants; Carbamazepine; Chemistry, Pharmaceutical; Chitosan; Crystallization; Drug Carriers; Linear Models; Microspheres; Oxcarbazepine; Particle Size; Polymers; Powders; Solubility; Technology, Pharmaceutical; Temperature; Wettability | 2007 |
Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery.
Topics: Alginates; Anticonvulsants; Carbamazepine; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Epilepsy; Ferric Compounds; Glucuronic Acid; Hexuronic Acids; Magnetics | 2010 |
Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine.
Topics: Animals; Anticonvulsants; Calorimetry, Differential Scanning; Carbamazepine; Chemistry, Pharmaceutical; Chitosan; Electric Stimulation; Male; Nanocapsules; Particle Size; Rats; Rats, Wistar; Seizures; Spectroscopy, Fourier Transform Infrared; Triglycerides | 2012 |
Sorption of carbamazepine from water by magnetic molecularly imprinted polymers based on chitosan-Fe₃O₄.
Topics: Adsorption; Carbamazepine; Chitosan; Ferric Compounds; Kinetics; Magnetics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molecular Imprinting; Polymers; Recycling; Temperature; Thermogravimetry; Water Pollutants, Chemical | 2013 |
Removal of selected pharmaceuticals from aqueous solution using magnetic chitosan: sorption behavior and mechanism.
Topics: Adsorption; Carbamazepine; Chitosan; Clofibric Acid; Diclofenac; Ferrosoferric Oxide; Hydrogen-Ion Concentration; Kinetics; Magnetic Phenomena; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Osmolar Concentration; Photoelectron Spectroscopy; Solutions; Water Pollutants, Chemical; Water Purification; X-Ray Diffraction | 2014 |
A systematic approach of chitosan nanoparticle preparation via emulsion crosslinking as potential adsorbent in wastewater treatment.
Topics: Adsorption; Carbamazepine; Chitosan; Cross-Linking Reagents; Diclofenac; Emulsions; Glutaral; Nanoparticles; Wastewater; Water Purification | 2018 |
Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles.
Topics: Administration, Oral; Animals; Anticonvulsants; Brain; Carbamazepine; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Lipids; Male; Mice; Nanoparticles; Particle Size; Polymers; Tissue Distribution | 2019 |
Chitosan-coated liposome-containing carbamazepine and coenzyme Q10: design, optimization and evaluation.
Topics: Carbamazepine; Chitosan; Humans; Liposomes; Particle Size; Ubiquinone | 2021 |